These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27513300)

  • 81. A review on ROCK-II inhibitors: From molecular modelling to synthesis.
    Shah S; Savjani J
    Bioorg Med Chem Lett; 2016 May; 26(10):2383-2391. PubMed ID: 27080184
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cytokine enhancement of immunogenicity in chronic myeloid leukaemia.
    Coleman S; Throp D; Fisher J; Bailey-Wood R; Lim SH
    Leukemia; 1997 Dec; 11(12):2055-9. PubMed ID: 9447820
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicity.
    Choudhury A; Toubert A; Sutaria S; Charron D; Champlin RE; Claxton DF
    Crit Rev Immunol; 1998; 18(1-2):121-31. PubMed ID: 9419454
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Calcium ionophore activation of chronic myelogenous leukemia progenitor cells into dendritic cells is mediated by calcineurin phosphatase.
    Engels FH; Kreisel D; Faries MB; Bedrosian I; Koski GK; Cohen PA; Czerniecki BJ
    Leuk Res; 2000 Oct; 24(10):795-804. PubMed ID: 10996197
    [TBL] [Abstract][Full Text] [Related]  

  • 85. HLA antigens in Sicilian patients affected by chronic myelogenous leukaemia.
    Caruso C; Lo Campo P; Botindari C; Modica MA
    J Immunogenet; 1987 Dec; 14(6):295-9. PubMed ID: 3509755
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients.
    Giallongo C; Parrinello N; Tibullo D; La Cava P; Romano A; Chiarenza A; Barbagallo I; Palumbo GA; Stagno F; Vigneri P; Di Raimondo F
    PLoS One; 2014; 9(7):e101848. PubMed ID: 25014230
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The chronic myeloid leukaemia story in the United Kingdom since 1960.
    Clark RE
    Br J Haematol; 2020 Nov; 191(4):521-526. PubMed ID: 33190253
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Glycolipid iGb3 feedback amplifies innate immune responses via CD1d reverse signaling.
    Liu X; Zhang P; Zhang Y; Wang Z; Xu S; Li Y; Huai W; Zhou Q; Chen X; Chen X; Li N; Wang P; Li Y; Cao X
    Cell Res; 2019 Jan; 29(1):42-53. PubMed ID: 30514903
    [TBL] [Abstract][Full Text] [Related]  

  • 89. FcRIII (CD16) expression on neutrophils from chronic myeloid leukemia. A flow cytometric study.
    Carulli G; Gianfaldoni ML; Azzara A; Papineschi F; Vanacore R; Minnucci S; Testi R; Ambrogi F
    Leuk Res; 1992 Dec; 16(12):1203-9. PubMed ID: 1465030
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Varicella zoster virus downregulates expression of the non-classical antigen presentation molecule CD1d.
    Traves R; Opadchy T; Slobedman B; Abendroth A
    J Infect Dis; 2023 Nov; ():. PubMed ID: 37972257
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Suppressive effect of circulating immune complexes on cytotoxicity of blood lymphocytes in patients with chronic myeloid leukemia].
    Guseva SA; Fed'ko AA; Volobueva ZV
    Gematol Transfuziol; 1992 Feb; 37(2):10-2. PubMed ID: 1426900
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Association between Altered Expression and Genetic Variations of Transforming Growth Factor β-Smad Pathway with Chronic Myeloid Leukemia.
    Shokeen Y; Sharma NR; Vats A; Dinand V; Beg MA; Sanskaran S; Minhas S; Jauhri M; Hariharan AK; Taneja V; Aggarwal S
    Int J Hematol Oncol Stem Cell Res; 2018 Jan; 12(1):14-22. PubMed ID: 29951173
    [No Abstract]   [Full Text] [Related]  

  • 93. Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells.
    Carrà G; Cartellà A; Maffeo B; Morotti A
    Blood Lymphat Cancer; 2019; 9():45-52. PubMed ID: 31807112
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Anthrax lethal toxin impairs CD1d-mediated antigen presentation by targeting the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway.
    Khan MA; Gallo RM; Brutkiewicz RR
    Infect Immun; 2010 May; 78(5):1859-63. PubMed ID: 20194602
    [TBL] [Abstract][Full Text] [Related]  

  • 95. PKM2 Is Required to Activate Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia.
    Liu C; Zheng M; Wang T; Jiang H; Fu R; Wang H; Ding K; Zhou Q; Shao Z
    Oxid Med Cell Longev; 2018; 2018():1364165. PubMed ID: 29636835
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Immunosuppressive action of polyamines in patients with chronic myeloid leukemia].
    Shardakov VI; Dem'ianova VT; Kopaneva TG
    Gematol Transfuziol; 1994; 39(1):9-11. PubMed ID: 8188035
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A clinical appraisal of chronic myeloid leukaemia (CML)-related death and CML-specific death-Are they synonymous?
    Eşkazan AE
    Int J Clin Pract; 2021 Jun; 75(6):e14217. PubMed ID: 33998756
    [No Abstract]   [Full Text] [Related]  

  • 98. Chronic myeloid leukaemia after chemoradiotherapy for solid malignancies.
    Baysal M; Ulutas G; Gokyer A; Umit E; Atli EI; Kirkizlar O; Gürkan H; Demir AM
    Natl Med J India; 2020; 33(6):347-348. PubMed ID: 34341212
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Epigenetic induction of CD1d expression primes lung cancer cells for killing by invariant natural killer T cells.
    Dockry É; O'Leary S; Gleeson LE; Lyons J; Keane J; Gray SG; Doherty DG
    Oncoimmunology; 2018; 7(6):e1428156. PubMed ID: 29872551
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity.
    Pinto-Fernandez A; Salio M; Partridge T; Chen J; Vere G; Greenwood H; Olie CS; Damianou A; Scott HC; Pegg HJ; Chiarenza A; Díaz-Saez L; Smith P; Gonzalez-Lopez C; Patel B; Anderton E; Jones N; Hammonds TR; Huber K; Muschel R; Borrow P; Cerundolo V; Kessler BM
    Br J Cancer; 2021 Feb; 124(4):817-830. PubMed ID: 33214684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.